Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma

BACKGROUND: Better treatments for glioblastoma (GBM) patients, in particular in the recurrent setting, are urgently needed. Clinical trials performed in Brazil indicated that intranasal delivery of perillyl alcohol (POH) might be effective in this patient group. NEO100, a highly purified version of...

Full description

Saved in:
Bibliographic Details
Published in:Neurooncol Adv
Main Authors: Schönthal, Axel H, Peereboom, David M, Wagle, Naveed, Lai, Rose, Mathew, Anna J, Hurth, Kyle M, Simmon, Vincent F, Howard, Steven P, Taylor, Lynne P, Chow, Frances, da Fonseca, Clovis O, Chen, Thomas C
Format: Artigo
Language:Inglês
Published: Oxford University Press 2021
Subjects:
Clinical Investigations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879254/
https://ncbi.nlm.nih.gov/pubmed/33604574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab005
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items